test

Karen Hager

@Blue Owl Capital Holdings Lp

Latest period2024 - Q3ReportedManaged Assets$518.429BTotal holdings137
Assets growth rate144084.03%Assets growth rate (2-Q avg)72027.93%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Blue Owl Capital Holdings Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 137 positions.

Assets under management

The assets under management (AUM) of Blue Owl Capital Holdings Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 518.429B in assets, with a quarterly growth rate of 144084.03% and a 2-quarter average growth rate of 72027.93%. The portfolio is managed by Karen Hager, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TRMLTourmaline Bio Inc
Recent Activity
Decreased -10.78%
7.59%
$39.347B
1.53M shares@ $25710.01 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
Decreased -1.86%
6.5%
$33.664B
2.011M shares@ $16740.0 avg price
SLRNAcelyrin Inc
Recent Activity
Decreased -4.51%
2.66%
$13.774B
2.794M shares@ $4930.01 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Decreased -39.14%
1.75%
$9.068B
163,238 shares@ $55550.01 avg price
IRONDisc Medicine Inc
Recent Activity
Decreased -18.58%
1.67%
$8.612B
175,260 shares@ $49140.0 avg price
KROSKeros Therapeutics Inc
Recent Activity
Decreased -22.2%
1.38%
$7.121B
122,633 shares@ $58070.0 avg price
MREOMereo Biopharma Group Plc
Recent Activity
Decreased -5.56%
0.68%
$3.484B
847,809 shares@ $4110.01 avg price
VKTXViking Therapeutics Inc
Recent Activity
Decreased -56.84%
0.51%
$2.596B↑ Call
41,000 shares@ $63310.0 avg price
MLYSMineralys Therapeutics Inc
Recent Activity
Decreased -56.44%
0.46%
$2.375B
196,132 shares@ $12110.01 avg price
PLMJUPlum Acquisition Corp Iii
Recent Activity
Decreased -78.57%
0%
$0
15,000 shares@ $0.0 avg price